 |
 |
 | CANCER CHEMOTHERAPY AND BIOLOGICAL RESPONSE MODIFIERS, 21
|  |
 |  |  |
 |
 |
Annual 21
To order this title, and for more information, click here
Edited By
Guiseppe Giaccone, MD, PhD, Department of Medical Oncology, Academic Hospital Vrije Universiteit, Amsterdam, The Netherlands
Richard Schilsky, MD, Associate Dean for Clinical Research, Biological Sciences Division, University of Chicago, Chicago, IL, USA
Paul Sondel, MD, PhD, Departments of Pediatrics, Human Oncology and Genetics, University of Wisconsin; Comprehensive Cancer Center, Madison, WI, USA
Description
Annual 21 contains an expanded section on Colorectal Cancer, an area that has seen remarkable progress in screening, early detection,
prevention and therapy in just the last few years. You will also see updates on biology and treatment of common malignancies as well
as chapters that summarise recent advances in chemotherapy and immunotherapy for cancer.
Contents
Section 1: Drugs
Thymidylate synthase inhibitors (SP Ackland, P Beale, GJ Peters); Anthracyclines (L Gianni, G Grasselli,
S Cresta, A Locatelli, L Vigano, G Minotti); Tubulin-targeting agents (WN Hait, E Rubin, S Goodin); Topoisomerase I interactive agents
(PK Turner, LC Iacono, CF Stewart); Topoisomerase II inhibitors (KR Hande); Farnesyltransferase inhibitors (AA Adjei); Cyclin-dependent
kinases as targets for cancer therapy (MA Shah, GK Schwartz); DNA-binding agents (Y Nieto); Advances in endocrine therapy for the treatment
and prevention of breast cancer (WJ Gradishar, VC Jordan)
Section 2: Biological Response Modifiers
Monoclonal
and antibody therapy for breast cancer: Herceptin (RS Finn, DJ Slamon); Rituximab (P Multani, CA White); Mucins in gastrointestinal cancers
(MS Turner, JR McKolanis, RK Ramanathan, DC Whitcomb, OJ Finn); HER-2/neu vaccines (ML Disis, K Schiffman, LG Salazar, B Almand, KL Knutson);
Colon cancer antigen and anti-idiotype vaccines (D Herlyn, B Birebent, N Akis, E Purev, R Somasundaram, E Mitchell, H Maguire, L Staib,
M Mastrangelo); Anti-carcinoembryonic antigen immunity (M DeBenedette, L Radvanyi, D Singh-Sandhu, NL Berinstein); Cancer gene therapy
and immunotherapy (Y Kawakami, TJ Curiel, DT Curiel); Recent areas of development for dendritic cell vaccines (MA Morse, S Chui, TM Clay,
HK Lyerly); Mechanisms of tumour evasion from the immune response (PC Rodriguez, AH Zea, AC Ochoa).
Section 3: Tumours
Plasma cell myeloma and leukemia (PH Wiernik); Lymphomas (A Santoro, L Castagna, M Magagnoli); Head and neck cancers (M Al-Sarraf, X
Guo); Lung cancer (G Giaccone, E Smit); Upper gastrointestinal tumours (K Aiba, M Ogawa); Cancers of the large bowel and hepatobiliary
tract (W Sun, D Haller); Neuroendocrine tumours - somatostatin receptor expression and somatostatin analog treatment (E Tiensuu Janson,
K Oberg); Genitourinary malignancies (MD Michaelson, MR Smith); Systematic therapy for gynaecological neoplasms: ovary, cervix and endometrium
(S Pecorelli, R Angioli, G Favalli, F Odicino); Breast cancer (P Valagussa, G Bonadonna); Melanoma - new developments in diagnosis and
therapy (A Schneeberger, SN Wagner); Sarcoma (M Scurr, I Judson); Brain tumors (JK Pueschel, LS Ashby, WR Shapiro); Biology and therapy
of malignant solid tumors in childhood (H van den Berg); Supportive care (M Markman); AIDS-associated malignancies (MH Shah, P Porcu,
SR Mallery, MA Caligiuri).
Special Section: Colorectal Cancer
Risk assessment and screening for colorectal
cancer (KE Kim); Non-steroidal and anti-inflammatory drugs (NSAIDs) for colorectal cancer prevention (ET Hawk, J Viner, E Richmond, A
Umar); Molecular predictors of prognosis and response to therapy in colorectal cancer (HL McLeod; RD Church); Combined modality therapy
for rectal cancer (BD Minsky); New drugs for colorectal cancer (PMG Hoff); Liver directed therapies for colorectal cancer (AS Wright,
DM Mahvi).
| Bibliographic details |
Hardbound, 916 pages, publication date: DEC-2003
ISBN-13: 978-0-444-51458-5
ISBN-10: 0-444-51458-9
Imprint: ELSEVIER
|
| Price and Ordering |
Price:
GBP 126.50 EUR 190 USD 190
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
063/631
Last update: 30 Nov 2009
|
 |
|  |
 |  |  |
 |
|
|  |